Perspectives of Women with Breast Cancer and Healthcare Providers Participating in an Adherence-Enhancing Program for Adjuvant Endocrine Therapy: A Qualitative Study
Abstract
:1. Introduction
2. Material & Methods
2.1. The SOIE Program Pilot RCT
2.2. Qualitative Study
2.2.1. Design and Participants
2.2.2. Data Collection
2.2.3. Data Analysis
3. Results
3.1. Program Appreciation
3.1.1. Overall Program
3.1.2. Educational Group Session
3.1.3. Nurse-Led Consultations
3.1.4. Online Chat Sessions
3.2. Perceived Impacts of the SOIE Program for Women
3.2.1. Knowledge, Attitude, Motivation, and Coping Strategies
3.2.2. Support from Healthcare Providers and Peers
3.3. Perceived Impacts of the SOIE Program for HCPs
4. Discussion
Limitations
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Huang, H.J.; Neven, P.; Drijkoningen, M.; Paridaens, R.; Wildiers, H.; Van Limbergen, E.; Berteloot, P.; Amant, F.; Vergote, I.; Christiaens, M.R. Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancer. J. Clin. Pathol. 2005, 58, 611–616. [Google Scholar] [CrossRef] [PubMed]
- Ma, H.; Lu, Y.; Marchbanks, P.A.; Folger, S.G.; Strom, B.L.; McDonald, J.A.; Simon, M.S.; Weiss, L.K.; Malone, K.E.; Burkman, R.T.; et al. Quantitative measures of estrogen receptor expression in relation to breast cancer-specific mortality risk among white women and black women. Breast Cancer Res. 2013, 15, R90. [Google Scholar] [CrossRef] [PubMed]
- Burstein, H.J.; Lacchetti, C.; Anderson, H.; Buchholz, T.A.; Davidson, N.E.; Gelmon, K.A.; Giordano, S.H.; Hudis, C.A.; Solky, A.J.; Stearns, V.; et al. Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update. J. Clin. Oncol. 2019, 37, 423–438. [Google Scholar] [CrossRef] [PubMed]
- Murphy, C.C.; Bartholomew, L.K.; Carpentier, M.Y.; Bluethmann, S.M.; Vernon, S.W. Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: A systematic review. Breast Cancer Res. Treat. 2012, 134, 459–478. [Google Scholar] [CrossRef] [PubMed]
- Huiart, L.; Ferdynus, C.; Giorgi, R. A meta-regression analysis of the available data on adherence to adjuvant hormonal therapy in breast cancer: Summarizing the data for clinicians. Breast Cancer Res. Treat. 2013, 138, 325–328. [Google Scholar] [CrossRef] [PubMed]
- Eliassen, F.M.; Blåfjelldal, V.; Helland, T.; Hjorth, C.F.; Hølland, K.; Lode, L.; Bertelsen, B.-E.; Janssen, E.A.M.; Mellgren, G.; Kvaløy, J.T.; et al. Importance of endocrine treatment adherence and persistence in breast cancer survivorship: A systematic review. BMC Cancer 2023, 23, 625. [Google Scholar] [CrossRef] [PubMed]
- Inotai, A.; Ágh, T.; Maris, R.; Erdősi, D.; Kovács, S.; Kaló, Z.; Senkus, E. Systematic review of real-world studies evaluating the impact of medication non-adherence to endocrine therapies on hard clinical endpoints in patients with non-metastatic breast cancer. Cancer Treat. Rev. 2021, 100, 102264. [Google Scholar] [CrossRef] [PubMed]
- Lambert, L.K.; Balneaves, L.G.; Howard, A.F.; Gotay, C.C. Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: An integrative review. Breast Cancer Res. Treat. 2017, 167, 615–633. [Google Scholar] [CrossRef]
- Paranjpe, R.; John, G.; Trivedi, M.; Abughosh, S. Identifying adherence barriers to oral endocrine therapy among breast cancer survivors. Breast Cancer Res. Treat. 2019, 174, 297–305. [Google Scholar] [CrossRef]
- Toivonen, K.I.; Williamson, T.M.; Carlson, L.E.; Walker, L.M.; Campbell, T.S. Potentially Modifiable Factors Associated with Adherence to Adjuvant Endocrine Therapy among Breast Cancer Survivors: A Systematic Review. Cancers 2020, 13, 107. [Google Scholar] [CrossRef]
- Moon, Z.; Moss-Morris, R.; Hunter, M.S.; Carlisle, S.; Hughes, L.D. Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: A systematic review. Patient Prefer. Adherence 2017, 11, 305–322. [Google Scholar] [CrossRef]
- Yussof, I.; Tahir, N.A.M.; Hatah, E.; Shah, N.M. Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: A systematic review. Breast 2022, 62, 22–35. [Google Scholar] [CrossRef]
- Xu, H.; Zhang, X.; Wang, D.; Xu, L.; Wang, A.-P. Factors influencing medication-taking behaviour with adjuvant endocrine therapy in women with breast cancer: A qualitative systematic review. J. Adv. Nurs. 2020, 76, 445–458. [Google Scholar] [CrossRef] [PubMed]
- Peddie, N.; Agnew, S.; Crawford, M.; Dixon, D.; MacPherson, I.; Fleming, L. The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: A qualitative systematic review and thematic synthesis. Breast 2021, 58, 147–159. [Google Scholar] [CrossRef] [PubMed]
- Bright, E.E.; Finkelstein, L.B.; Nealis, M.S.; Genung, S.R.; Wrigley, J.; Gu, H.C.J.; Schmiege, S.J.; Arch, J.J. A Systematic Review and Meta-Analysis of Interventions to Promote Adjuvant Endocrine Therapy Adherence Among Breast Cancer Survivors. J. Clin. Oncol. 2023, 41, 4548–4561. [Google Scholar] [CrossRef] [PubMed]
- Graetz, I.; Hu, X.; Kocak, M.; Krukowski, R.A.; Anderson, J.N.; Waters, T.M.; Curry, A.N.; Robles, A.; Paladino, A.; Stepanski, E.; et al. Remote Monitoring App for Endocrine Therapy Adherence Among Patients With Early-Stage Breast Cancer. JAMA Netw. Open 2024, 7, e2417873. [Google Scholar] [CrossRef] [PubMed]
- Graham, C.D.; Ellison, R.; Hall, L.H.; Clark, J.; McNaught, E.; Green, S.M.C.; Wilkes, H.; Robson, G.; Lorentz, I.; Holmes, L.; et al. A pilot randomised controlled trial of acceptance and commitment therapy for medication decision-making and quality of life in women with breast cancer: The ACTION trial. Psycho-Oncology 2024, 33, e6349. [Google Scholar] [CrossRef]
- Gagné, M.; Lauzier, S.; Lemay, M.; Loiselle, C.G.; Provencher, L.; Simard, C.; Guillaumie, L. Women with breast cancer’s perceptions of nurse-led telephone-based motivational interviewing consultations to enhance adherence to adjuvant endocrine therapy: A qualitative study. Support. Care Cancer 2022, 30, 4759–4768. [Google Scholar] [CrossRef] [PubMed]
- Creswell, J.W.; Clark, V.L.P. Designing and Conducting Mixed Methods Research, 3rd ed.; SAGE: Thousand Oaks, CA, USA, 2017. [Google Scholar]
- Assan, O.; Memoli, V.; Guillaumie, L.; Turcotte, V.; Lemay, M.; Dionne, A.; Lemieux, J.; Provencher, L.; Gotay, C.; de Bruin, M.; et al. Pilot randomized controlled trial of a program to enhance experience and adherence with adjuvant endocrine therapy among women with non-metastatic breast cancer: 12-month quantitative results. J. Cancer Surviv. 2024. ahead of print. [Google Scholar] [CrossRef]
- Graneheim, U.H.; Lundman, B. Qualitative content analysis in nursing research: Concepts, procedures and measures to achieve trustworthiness. Nurse Educ. Today 2004, 24, 105–112. [Google Scholar] [CrossRef]
- Palinkas, L.A.; Horwitz, S.M.; Green, C.A.; Wisdom, J.P.; Duan, N.; Hoagwood, K. Purposeful Sampling for Qualitative Data Collection and Analysis in Mixed Method Implementation Research. Adm. Policy Ment. Health Ment. Health Serv. Res. 2015, 42, 533–544. [Google Scholar] [CrossRef] [PubMed]
- Paillé, P.; Mucchielli, A. L’analyse Qualitative en Sciences Humaines et Sociales; Armand Colin: Paris, France, 2003. [Google Scholar]
- Fereday, J.; Muir-Cochrane, E. Demonstrating rigor using thematic analysis: A hybrid approach of inductive and deductive coding and theme development. Int. J. Qual. Methods 2006, 5, 80–92. [Google Scholar] [CrossRef]
- Paillé, P. L’analyse par théorisation ancrée. Cah. Rech. Sociol. 1994, 23, 147–181. [Google Scholar] [CrossRef]
- Camiré-Bernier, É.; Nidelet, E.; Baghdadli, A.; Demers, G.; Boulanger, M.-C.; Brisson, M.-C.; Michon, B.; Lauzier, S.; Laverdière, I. Parents’ Experiences with Home-Based Oral Chemotherapy Prescribed to a Child Diagnosed with Acute Lymphoblastic Leukemia: A Qualitative Study. Curr. Oncol. 2021, 28, 4377–4391. [Google Scholar] [CrossRef]
- Humphries, B.; Collins, S.; Guillaumie, L.; Lemieux, J.; Dionne, A.; Provencher, L.; Moisan, J.; Lauzier, S. Women’s Beliefs on Early Adherence to Adjuvant Endocrine Therapy for Breast Cancer: A Theory-Based Qualitative Study to Guide the Development of Community Pharmacist Interventions. Pharmacy 2018, 6, 53. [Google Scholar] [CrossRef] [PubMed]
- Guest, G.; Bunce, A.; Johnson, L. How Many Interviews Are Enough? An experiment with data saturation and variability. Field Methods 2006, 18, 59–82. [Google Scholar] [CrossRef]
- Miles, M.B.; Huberman, A.M.; Saldana, J. Qualitative Data Analysis: A Methods Sourcebook, 4th ed.; SAGE Publications, Inc.: Los Angeles, CA, USA, 2018. [Google Scholar]
- Arch, J.J.; Crespi, C.M.; Levin, M.E.; Genung, S.R.; Nealis, M.; Mitchell, J.L.; Bright, E.E.; Albright, K.; Magidson, J.F.; Stanton, A.L. Randomized Controlled Pilot Trial of a Low-Touch Remotely-Delivered Values Intervention to Promote Adherence to Adjuvant Endocrine Therapy Among Breast Cancer Survivors. Ann. Behav. Med. 2022, 56, 856–871. [Google Scholar] [CrossRef]
- Ell, K.; Vourlekis, B.; Xie, B.; Nedjat-Haiem, F.R.; Lee, P.; Muderspach, L.; Russell, C.; Palinkas, L.A. Cancer treatment adherence among low-income women with breast or gynecologic cancer. Cancer 2009, 115, 4606–4615. [Google Scholar] [CrossRef]
- Moon, Z.; Moss-Morris, R.; Hunter, M.S.; Goodliffe, S.; Hughes, L.D. Acceptability and feasibility of a self-management intervention for women prescribed tamoxifen. Health Educ. J. 2019, 78, 901–915. [Google Scholar] [CrossRef]
- AlOmeir, O.; Patel, N.; Donyai, P. Adherence to adjuvant endocrine therapy among breast cancer survivors: A systematic review and meta-synthesis of the qualitative literature using grounded theory. Support. Care Cancer 2020, 28, 5075–5084. [Google Scholar] [CrossRef] [PubMed]
- William, R.; Miller, S. Motivational Interviewing: Helping People Change, 3rd ed.; The Guilford Press: Washington, DC, USA, 2012. [Google Scholar]
- Shaver, J. The State of Telehealth Before and After the COVID-19 Pandemic. Prim. Care Clin. Off. Pract. 2022, 49, 517–530. [Google Scholar] [CrossRef] [PubMed]
- Brown, N.W. Facilitating Challenging Groups: Leaderless, Open, and Single Session Groups; Routledge: New York, NY, USA, 2013. [Google Scholar] [CrossRef]
n | % | |
---|---|---|
Age | ||
40–49 | 2 | 10 |
50–59 | 8 | 40 |
60–69 | 7 | 35 |
70–79 | 2 | 10 |
80–89 | 1 | 5 |
Higher level of education | ||
Secondary school | 4 | 20 |
College degree 1 | 4 | 20 |
Professional diploma | 3 | 15 |
Bachelor degree | 4 | 20 |
Masters’ or PhD degree | 5 | 25 |
Type of AET 2 | ||
Aromatase inhibitors | 13 | 65 |
Tamoxifen | 4 | 20 |
Both | 3 | 15 |
AET adherence | ||
Took AET during the study | 19 | 95 |
Had stopped to take AET during the study | 1 | 5 |
n | ||
---|---|---|
Sex | ||
Man | 0 | |
Woman | 7 | |
Age | ||
25–34 | 1 | |
35–44 | 2 | |
45–54 | 3 | |
55–64 | 1 | |
Profession | ||
Nurse navigator | 3 | |
Pharmacist | 3 | |
Social worker | 1 | |
Higher level of education | ||
Bachelor degree | 4 | |
Master degree | 3 | |
Years of practice in their profession | ||
Mean | 19.6 | |
Years of practice at the breast cancer center | ||
Mean | 12.8 | |
Years of practice with women with breast cancer | ||
Mean | 14.4 | |
Estimated proportion of patients with breast cancer in their caseload | ||
Mean | 84.2 |
Program Appreciation |
---|
Overall program Quotation #1: “So it went well. Really. I have nothing but good things to say about SOIE. I loved it. If I had to start all over again tomorrow and somebody were to ask, “Uh, should I do it or not?” I’d tell them, “Go for it. Do it. It’s a huge help. It gives you the support you need, when you need it, because this is tough [AET].” (Woman 113) Quotation #2: “And the last one [telephone consultation], the second one, you know, um, it happens around the one-year mark. After a year, we notice that demotivation sets in with our patients. So, this program allows us to check on them and see if they’re ready for the next steps.” (Healthcare Provider 01) Quotation #3: “[…] I was better prepared and it showed, even in the advice I gave, because I found the document to be, comprehensive and up to date. It was a huge help.” (Healthcare provider 05) |
Educational group session Quotation #4: “We saw that they [patients sharing testimonies] were faring. There were difficult moments and some easier ones, but there was a light at the end of the tunnel.” (Woman 089) |
Nurse-led consultations Quotation #5: “Getting help from a nurse who knows your symptoms and your medication, and who gives you solutions adapted to YOUR situation, YOUR life, YOUR routine, and YOUR personality—that’s HUGE. Having access to this resource was a big plus.” (Woman 006) Quotation #6: “The women were very receptive. […] There was a willingness to rally together and pull through. […] If a problem came up, they were open to trying other strategies, trying something to get better.” (Healthcare provider 09) |
Online chat sessions Quotation #7: “Sometimes we didn’t have time to read what the others have written. We were getting ready to write a comment, but it was too late.” (Woman 094). Quotation #8: “I found it really easy to access (…) It was easy to use, it was still intuitive. It looks like what we’re used to using. Even the older patients were fine with it. (…) I really liked it as a platform”. (Healthcare provider 07)” Quotation #9: “It was just a computer. I asked it questions and got answers, but not much of a human interaction, though.” (Woman 006) |
Perceived impacts of the SOIE program for women |
Knowledge, attitude, motivation and coping strategies Quotation #10: “I liked (…) that they took the time to really explain the side effects of the antihormone. […] You know what to expect and that’s reassuring. […] It helps build trust.” (Woman 089) Quotation #11: “We learned that we could get such and such side effects. It was all in the guide, so we had resources! It helps a lot at the start. You don’t feel like you’re in the dark. You get a better understanding. It’s important to be well informed”. (Woman 113) Quotation #12: “I mean cancer is scary, and this program […] helped me stay positive. […] If I hadn’t had all this information, I probably would have given up on the pill after the first side effects.” (Woman 209) Quotation #13: “I felt like I had more tools to help me get through this… Between the information, the video, the information booklet, and other stuff, I felt like I came out more prepared, you know?” (Woman 199) |
Support from healthcare providers and peers Quotation #14: “Um, so (sigh) having a person on the other end of the line who understood what we were going through and could guide us through the steps too was reassuring. You know, for me it’s a matter of bringing comfort and information to this whole journey.” (Woman 004) Quotation #15: “Being able to share our ways of getting through this with others is really great and so rewarding.” (Woman 113) Quotation #16: “Knowing that I’m not alone in this was a great source of motivation. Seeing that there were other people going through this, living with this, just like I was, you know?” (Woman 043) Quotation #17: “In times like these, we didn’t need any more negative energy in our lives. We wanted good vibes because there was a LOT of negativity.” (Woman 138) |
Perceived impacts of the SOIE program for HCPs |
Quotation #18: “You know, if one day there was a general training out there on hormone therapy, I think it […] would lead to fewer calls. […] I think that if something like that […] eventually became like a “prerequisite,” patients would […] be better informed and have all the tools they needed to manage these side effects. And that would also help professionals.” (Healthcare provider 01) Quotation #19: “I think that if I didn’t have all the information, I would have been making calls left and right to find out what was going on because I wouldn’t have understood what was happening to me.” (Woman 113) Quotation #20: “The program ensured the continuity of the process since we were very well supported there. […] You know, from the time you’re diagnosed until your last radiation treatment, you have all the support you need, but then you’re left with nothing. That’s where the program comes in. […] It gives you the push you need to keep going.” (Woman 199) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Turcotte, V.; Guillaumie, L.; Lemay, M.; Dionne, A.; Lemieux, J.; Labbé, A.; Gotay, C.; Guénette, L.; Lauzier, S. Perspectives of Women with Breast Cancer and Healthcare Providers Participating in an Adherence-Enhancing Program for Adjuvant Endocrine Therapy: A Qualitative Study. Curr. Oncol. 2025, 32, 45. https://doi.org/10.3390/curroncol32010045
Turcotte V, Guillaumie L, Lemay M, Dionne A, Lemieux J, Labbé A, Gotay C, Guénette L, Lauzier S. Perspectives of Women with Breast Cancer and Healthcare Providers Participating in an Adherence-Enhancing Program for Adjuvant Endocrine Therapy: A Qualitative Study. Current Oncology. 2025; 32(1):45. https://doi.org/10.3390/curroncol32010045
Chicago/Turabian StyleTurcotte, Véronique, Laurence Guillaumie, Martine Lemay, Anne Dionne, Julie Lemieux, Angéline Labbé, Carolyn Gotay, Line Guénette, and Sophie Lauzier. 2025. "Perspectives of Women with Breast Cancer and Healthcare Providers Participating in an Adherence-Enhancing Program for Adjuvant Endocrine Therapy: A Qualitative Study" Current Oncology 32, no. 1: 45. https://doi.org/10.3390/curroncol32010045
APA StyleTurcotte, V., Guillaumie, L., Lemay, M., Dionne, A., Lemieux, J., Labbé, A., Gotay, C., Guénette, L., & Lauzier, S. (2025). Perspectives of Women with Breast Cancer and Healthcare Providers Participating in an Adherence-Enhancing Program for Adjuvant Endocrine Therapy: A Qualitative Study. Current Oncology, 32(1), 45. https://doi.org/10.3390/curroncol32010045